Zengfeng Pan

792 total citations
17 papers, 556 citations indexed

About

Zengfeng Pan is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Zengfeng Pan has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Zengfeng Pan's work include Inflammatory Bowel Disease (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Eosinophilic Esophagitis (2 papers). Zengfeng Pan is often cited by papers focused on Inflammatory Bowel Disease (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Eosinophilic Esophagitis (2 papers). Zengfeng Pan collaborates with scholars based in China. Zengfeng Pan's co-authors include Lian Zhou, Xia Luo, Jinyan Chen, Shaowei Huang, Junjie Liang, Yu‐Lin Su, Yanyang Li, Xueqian Xie, Qing Wang and Xiaojing Wang and has published in prestigious journals such as Biochemical Pharmacology, Journal of Ethnopharmacology and Phytotherapy Research.

In The Last Decade

Zengfeng Pan

16 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zengfeng Pan China 12 285 142 133 116 52 17 556
Gong Yang China 11 227 0.8× 155 1.1× 99 0.7× 99 0.9× 41 0.8× 23 491
Yugen Chen China 12 358 1.3× 110 0.8× 74 0.6× 90 0.8× 37 0.7× 26 593
Lei Shen China 15 326 1.1× 97 0.7× 196 1.5× 90 0.8× 26 0.5× 30 707
Feifei Nong China 10 300 1.1× 115 0.8× 75 0.6× 75 0.6× 71 1.4× 15 487
Gaiyan Ren China 8 212 0.7× 124 0.9× 104 0.8× 126 1.1× 66 1.3× 8 498
Yonger Chen China 14 287 1.0× 70 0.5× 70 0.5× 124 1.1× 49 0.9× 20 609
Guang Chen China 15 195 0.7× 68 0.5× 76 0.6× 88 0.8× 58 1.1× 27 514
Minyao Li China 11 228 0.8× 110 0.8× 56 0.4× 97 0.8× 39 0.8× 20 442
Shaowei Huang China 9 241 0.8× 74 0.5× 88 0.7× 65 0.6× 89 1.7× 18 479
Supriya R. Hyam South Korea 10 440 1.5× 79 0.6× 154 1.2× 132 1.1× 61 1.2× 10 733

Countries citing papers authored by Zengfeng Pan

Since Specialization
Citations

This map shows the geographic impact of Zengfeng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengfeng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengfeng Pan more than expected).

Fields of papers citing papers by Zengfeng Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengfeng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengfeng Pan. The network helps show where Zengfeng Pan may publish in the future.

Co-authorship network of co-authors of Zengfeng Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Zengfeng Pan. A scholar is included among the top collaborators of Zengfeng Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zengfeng Pan. Zengfeng Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Yunliang, Zengfeng Pan, Shunsheng Cao, et al.. (2025). Glycyrrhizic acid reduces neutrophil extracellular trap formation to ameliorate colitis-associated colorectal cancer by inhibiting peptidylarginine deiminase 4. Journal of Ethnopharmacology. 341. 119337–119337. 4 indexed citations
3.
Pan, Zengfeng, et al.. (2025). Gancao Xiexin decoction attenuated experimental colitis through suppressing ACSL4-mediated ferroptosis. Journal of Ethnopharmacology. 344. 119532–119532. 3 indexed citations
4.
Huang, Qiuhua, Xiaoyan Tang, Qiaoting Deng, et al.. (2025). EFHD1 Activates SIK3 to Limit Colorectal Cancer Initiation and Progression via the Hippo Pathway. Journal of Cancer. 16(4). 1348–1362.
5.
Huang, Shaowei, Xueqian Xie, Bo Xu, et al.. (2024). Paeoniflorin ameliorates chronic colitis via the DR3 signaling pathway in group 3 innate lymphoid cells. Journal of Pharmaceutical Analysis. 14(6). 100940–100940. 4 indexed citations
6.
Wang, Xiao‐Jing, Yanyang Li, Xueqian Xie, et al.. (2023). Quercetin ameliorates ulcerative colitis by activating aryl hydrocarbon receptor to improve intestinal barrier integrity. Phytotherapy Research. 38(1). 253–264. 48 indexed citations
7.
Wang, Chunli, Zengfeng Pan, Ruoyu Zhou, et al.. (2023). Baitouweng decoction repairs the intestinal barrier in DSS-induced colitis mice via regulation of AMPK/mTOR-mediated autophagy. Journal of Ethnopharmacology. 318(Pt A). 116888–116888. 20 indexed citations
8.
Huang, Shaowei, Xiaojing Wang, Xueqian Xie, et al.. (2022). Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3. Journal of Ethnopharmacology. 299. 115652–115652. 36 indexed citations
9.
Xie, Xueqian, Meng Zhao, Shaowei Huang, et al.. (2022). Luteolin alleviates ulcerative colitis by restoring the balance of NCR-ILC3/NCR+ILC3 to repairing impaired intestinal barrier. International Immunopharmacology. 112. 109251–109251. 25 indexed citations
10.
Wang, Xiaojing, Shaowei Huang, Meiling Zhang, et al.. (2022). Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice. Journal of Ethnopharmacology. 302(Pt B). 115919–115919. 62 indexed citations
11.
Pan, Zengfeng, Yunliang Chen, Junjie Liang, et al.. (2022). Huang Qin Decoction inhibits the initiation of experimental colitis associated carcinogenesis by controlling the PAD4 dependent NETs. Phytomedicine. 107. 154454–154454. 24 indexed citations
12.
Su, Yu‐Lin, Junjie Liang, Meng Zhao, et al.. (2022). Wogonin regulates colonocyte metabolism via PPARγ to inhibit Enterobacteriaceae against dextran sulfate sodium‐induced colitis in mice. Phytotherapy Research. 37(3). 872–884. 12 indexed citations
13.
Li, Yanyang, Xiaojing Wang, Yu‐Lin Su, et al.. (2021). Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s. Acta Pharmacologica Sinica. 43(6). 1495–1507. 166 indexed citations
14.
Liu, Qi, Rui Zuo, Kai Wang, et al.. (2020). Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway. Acta Pharmacologica Sinica. 41(6). 771–781. 55 indexed citations
15.
Pan, Zengfeng, Yuan Zhou, Xia Luo, et al.. (2018). Against NF-κB/thymic stromal lymphopoietin signaling pathway, catechin alleviates the inflammation in allergic rhinitis. International Immunopharmacology. 61. 241–248. 36 indexed citations
16.
Luo, Shuang, Xiangliang Deng, Qi Liu, et al.. (2018). Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice. International Immunopharmacology. 59. 269–275. 49 indexed citations
17.
Luo, Xia, Zengfeng Pan, Shuang Luo, et al.. (2018). Effects of ceftriaxone-induced intestinal dysbacteriosis on regulatory T cells validated by anaphylactic mice. International Immunopharmacology. 60. 221–227. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026